Search
Blog Post
New options for KRAS-associated cancers available at Roswell Park
… — or who develop resistance — to the drug,” says Christos Fountzilas, MD, FACP, Associate Professor of Oncology and … in my trial takes a different approach,” explains Dr. Fountzilas. “It binds to the KRAS molecule and breaks it …
Program Members
… Clinical Assistant Instructor, Health Sciences Christos Fountzilas, MD, FACP Associate Professor of Oncology Zhihong …
Clinical Trial
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 3 Trial of Quemliclustat and Chemotherapy Versus Placebo and Chemotherapy in Patients With Treatment-Naive Metastatic Pancreatic Ductal Adenocarcinoma
… Metastatic Pancreatic Ductal Adenocarcinoma III Fountzilas, Christos The purpose of this study is to compare …
Clinical Trial
RASolute 302: A Phase 3 Multicenter, Open-label, Randomized Study of RMC-6236 versus Investigator's Choice of Standard of Care Therapy in Patients with Previously Treated Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
… Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) III Fountzilas, Christos The purpose of this study is to evaluate …
Graduate Education
Clinical Oncology Year 2019 in Review Presentations
… MD Updates in Management of GI Malignancies / Christos Fountzilas, MD Updates in Lung Cancer Treatments / Edwin Yau, … MD Updates in Management of GI Malignancies / Christos Fountzilas, MD Updates in Lung Cancer Treatments / Edwin Yau, …
Graduate Education
Clinical Oncology Year 2019 in Review Presentations
… MD Updates in Management of GI Malignancies / Christos Fountzilas, MD Updates in Lung Cancer Treatments / Edwin Yau, … MD Updates in Management of GI Malignancies / Christos Fountzilas, MD Updates in Lung Cancer Treatments / Edwin Yau, …
Page with Layout
Bakin Lab Publications
… B, Foster BA, Rajan P, Attwood K, Chatley S, Iyer R, Fountzilas C, Bakin AV. Citation: Cell Rep Med. 2024 Mar … Smith B, Melnick M, Eng KH, Melendy T, Park BH, Iyer R, Fountzilas C, Bakin AV. Citation: Commun Biol. 2021 Jul …
Blog Post
What's New in Pancreatic Cancer Research?
… to treat it. “We should always have hope,” says Christos Fountzilas, MD, FACP , Department of Medical Oncology at … existing therapy. Some of the latest developments that Dr. Fountzilas considers exciting are new agents that target the …
News
Roswell Park Clinical Trials Add Beta Blocker to Arsenal Against Esophageal Cancer
… chemotherapy, and it becomes progressive.” Dr. Christos Fountzilas “Roswell Park is at the forefront of research on … and radiation in those patients,” says Christos Fountzilas, MD, FACP , Co-Leader of the Gastrointestinal …
Clinical Trial
A Phase III, Randomized, Controlled, Global Multicenter Study to Evaluate the Efficacy and Safety of Oral Tinengotinib versus Physician s Choice in Subjects with Fibroblast Growth Factor Receptor (FGFR)-altered, Chemotherapy- and FGFR Inhibitor…
… (FGFR)-altered, Chemotherapy- and FGFR Inhibitor… III Fountzilas, Christos This study is a Phase III, Randomized, …